PET/CT for non-small-cell lung cancer staging
Published
05 July 2012
| Article by Journal of Biomedicine and Biotechnology 2012 (2012)
PET/CT for non-small-cell lung cancer staging
Lung cancer, with 80–85% being non-small-cell lung cancer (NSCLC), is the leading cause of cancer-related death in both men and women in the western world . In 2008, 215,020 new cases are expected and 161,840 persons are projected to die from the disease in the United States . Adequate therapeutic...
To read the full article, please register for GetInsideHealth below.
Register for GetInsideHealth
GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.
Please fill in the form below to register.
Already Registered?
Please login using
form at top of page
Fields with an asterisk (*) are mandatory
About you
Login information
Newsletter
Additional information